Related MeSH Hierarchy (8)
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Kidney Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urologic Neoplasms » Kidney Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Kidney Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Kidney Diseases » Kidney Neoplasms
Hierarchy View
Subtype Terms (3)
Carcinoma, Renal Cell
552 drugs (173 approved, 379 experimental)
Wilms Tumor
84 drugs (50 approved, 34 experimental)
Phase 4 Indicated Drugs (22)
Phase 3 Indicated Drugs (32)
Phase 2 Indicated Drugs (140)
allogeneic hematopoietic stem cells (Hemacord)
allogeneic natural killer cells
anti-p53 t-cell receptor-transduced peripheral blood lymphocytes
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)
interferon gamma-1b (actimmune)
muromonab cd3 (Orthoclone OKT3)
Phase 1 Indicated Drugs (49)
124i-iodo-azomycin galacto-pyranoside
2g-1 tcr retroviral vector-transduced lyn
herv-e tcr transduced cd8+/cd34+ t cells in hlaa* 11:01 positive patients
human prostate-specific membrane antigen plasmid dna vaccine
Other Experimental Indicated Drugs (23)
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (68)
Cancer and Leukemia Group B (CALGB)
Central European Cooperative Oncology Group
Children's Cancer and Leukaemia Group
Eastern Cooperative Oncology Group
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
Groupe D'Etude des Tumeurs Uro-Genitales
HonorHealth Research Institute
Huazhong University of Science and Technology
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Katholieke Universiteit Leuven
Klinikum Nuernberg - Klinikum Nord
Oregon Health and Science University
Royal Marsden Hospital NHS Trust
Societe Francaise Oncologie Pediatrique
Spanish Oncology Genito-Urinary Group
State University of New York, Buffalo
Universidad Autonoma de Barcelona
Organization Involved with Phase 2 Indications (151)
Associació per a la Recerca Oncologica, Spain
Associacio Per la Recerca Oncológica
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Big Ten Cancer Research Consortium
Cancer Biotherapy Research Group
Cancer Immunotherapy Trials Network
Cancer Treatment Centers of America
Central European Society for Anticancer Drug Research (CESAR)
Centre Georges Francois Leclerc
City of Hope National Medical Center
Clinical Research Technology S.r.l.
Developmental Therapeutics Consortium
Fundacion Instituto Valenciano de Oncologia
Gruppo Italiano Carcinoma Renale
Gruppo Oncologico Italiano di Ricerca Clinica
Hellenic Cooperative Oncology Group
Herbert Irving Comprehensive Cancer Center
Hoag Memorial Hospital Presbyterian
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Istituto Clinico Humanitas - Rozzano (MI), Italy
Istituto Nazionale per lo Studio e la Cura dei Tumori
Ludwig Institute for Cancer Research
Medical University of South Carolina
National Heart, Lung, and Blood Institute (NHLBI)
Netherlands Working Group on Immunotherapy of Oncology
Russian Academy of Medical Sciences
St. Vincent Medical Center - Los Angeles
The Christie NHS Foundation Trust
The Royal Bournemouth Hospital
The University of Texas, Dallas
Universidad Complutense de Madrid
University of California, Berkeley
University of California, Davis
University of Medicine and Dentistry of New Jersey
University of Nice Sophia Antipolis
University of Southern California
University of Texas at Houston
University of Texas, San Antonio
Organization Involved with Phase 1 Indications (41)
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
